Cemil Bayram

427 total citations
27 papers, 203 citations indexed

About

Cemil Bayram is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Complementary and alternative medicine. According to data from OpenAlex, Cemil Bayram has authored 27 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 5 papers in Complementary and alternative medicine. Recurrent topics in Cemil Bayram's work include Chemotherapy-induced organ toxicity mitigation (6 papers), Nigella sativa pharmacological applications (4 papers) and Pancreatic function and diabetes (4 papers). Cemil Bayram is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (6 papers), Nigella sativa pharmacological applications (4 papers) and Pancreatic function and diabetes (4 papers). Cemil Bayram collaborates with scholars based in Türkiye, United Kingdom and Sweden. Cemil Bayram's co-authors include Ahmet Hacımüftüoğlu, Irmak Ferah Okkay, Ufuk Okkay, Tae Woo Jung, Ji Hoon Jeong, A.M. Abd El‐Aty, Medine Güllüce, Mustafa Özkaraca, Leyla Güven and Ali Taghizadehghalehjoughi and has published in prestigious journals such as Biochemical Pharmacology, Journal of Pharmaceutical Sciences and eLife.

In The Last Decade

Cemil Bayram

22 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cemil Bayram Türkiye 9 55 29 26 26 24 27 203
Ufuk Okkay Türkiye 11 92 1.7× 36 1.2× 39 1.5× 35 1.3× 36 1.5× 31 302
Dalia Zaafar Egypt 14 106 1.9× 27 0.9× 29 1.1× 20 0.8× 26 1.1× 33 357
Noha E. Farag Egypt 10 79 1.4× 19 0.7× 18 0.7× 19 0.7× 17 0.7× 14 295
Cristina Nicula Romania 14 64 1.2× 21 0.7× 46 1.8× 24 0.9× 24 1.0× 55 553
Xiao Lü China 8 90 1.6× 38 1.3× 16 0.6× 25 1.0× 16 0.7× 15 327
Wafaa Ibrahim Egypt 13 113 2.1× 34 1.2× 20 0.8× 38 1.5× 40 1.7× 43 463
Ibtesam S. Alanazi Saudi Arabia 8 88 1.6× 31 1.1× 12 0.5× 46 1.8× 23 1.0× 12 283
Fenglian Yang China 10 86 1.6× 44 1.5× 11 0.4× 16 0.6× 21 0.9× 21 314
Ahmad Khusairi Azemi Malaysia 10 53 1.0× 32 1.1× 9 0.3× 21 0.8× 26 1.1× 27 266
Yusuf Hussain India 11 102 1.9× 32 1.1× 36 1.4× 24 0.9× 32 1.3× 25 340

Countries citing papers authored by Cemil Bayram

Since Specialization
Citations

This map shows the geographic impact of Cemil Bayram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cemil Bayram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cemil Bayram more than expected).

Fields of papers citing papers by Cemil Bayram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cemil Bayram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cemil Bayram. The network helps show where Cemil Bayram may publish in the future.

Co-authorship network of co-authors of Cemil Bayram

This figure shows the co-authorship network connecting the top 25 collaborators of Cemil Bayram. A scholar is included among the top collaborators of Cemil Bayram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cemil Bayram. Cemil Bayram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Türkez, Hasan, et al.. (2025). Colemanite and biological disruptions: Behavioral, neurological, and physiological findings. Regulatory Toxicology and Pharmacology. 161. 105840–105840.
4.
Bayram, Cemil, et al.. (2024). Experimental Models in Parkinson’s Disease: Advantages and Disadvantages. DergiPark (Istanbul University). 2(2). 80–87. 4 indexed citations
5.
Okkay, Irmak Ferah, Ufuk Okkay, Cemil Bayram, et al.. (2024). Protective effects of arbutin against doxorubicin-induced cardiac damage. Molecular Biology Reports. 51(1). 532–532. 5 indexed citations
6.
Okkay, Ufuk, et al.. (2023). In silico study of synthetic Bromophenol Compounds against Staphylococcus aeurus's target protein (DHFR) Enzyme. DergiPark (Istanbul University).
7.
Bayram, Cemil, et al.. (2023). Role of parthenolide in paclitaxel-induced oxidative stress injury and impaired reproductive function in rat testicular tissue. Chemico-Biological Interactions. 387. 110793–110793. 6 indexed citations
8.
Hacımüftüoğlu, Ahmet, et al.. (2023). Use of bee venom in preventive medicine: An experimental hepatic encephalopathy study in rats. Veterinary Medicine and Science. 10(1). e1336–e1336.
9.
Bayram, Cemil, et al.. (2023). Assessment of antimicrobial activity and In Vitro wound healing potential of ZnO nanoparticles synthesized with Capparis spinosa extract. Environmental Science and Pollution Research. 30(55). 117609–117623. 16 indexed citations
10.
Çetin, Meltem, et al.. (2023). In Vivo Evaluation of Nanoemulsion Formulations for Metformin and Repaglinide Alone and Combination. Journal of Pharmaceutical Sciences. 112(5). 1411–1426. 10 indexed citations
11.
Bayram, Cemil, et al.. (2023). The in-vitro Wound Healing Potential of Essential Oil Extracted from Mentha longifolia L.. Journal of Research in Pharmacy. 27(3)(27(3)). 1220–1233. 3 indexed citations
12.
Bayram, Cemil, et al.. (2023). Parthenolide as a potential analgesic in the treatment of paclitaxel-induced neuropathic pain: the rat modeling. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(12). 3707–3721. 4 indexed citations
13.
Okkay, Ufuk, et al.. (2022). Behavioral Tests Used in Experimental Animal Models. DergiPark (Istanbul University). 1 indexed citations
14.
Park, Tae Jun, Seung Yeon Park, Hyun Jung Lee, et al.. (2022). Developmental endothelial locus-1 attenuates palmitate-induced apoptosis in tenocytes through the AMPK/autophagy-mediated suppression of inflammation and endoplasmic reticulum stress. Bone and Joint Research. 11(12). 854–861. 8 indexed citations
15.
Okkay, Irmak Ferah, et al.. (2022). Centella asiatica extract protects against cisplatin-induced hepatotoxicity via targeting oxidative stress, inflammation, and apoptosis. Environmental Science and Pollution Research. 29(22). 33774–33784. 13 indexed citations
17.
Tozlu, Özlem Özdemir, Hasan Türkez, Ufuk Okkay, et al.. (2022). Assessment of the neuroprotective potential of d-cycloserine and l-serine in aluminum chloride-induced experimental models of Alzheimer’s disease: In vivo and in vitro studies. Frontiers in Nutrition. 9. 981889–981889. 7 indexed citations
19.
Okkay, Irmak Ferah, et al.. (2021). Syringic acid protects against thioacetamide-induced hepatic encephalopathy: Behavioral, biochemical, and molecular evidence. Neuroscience Letters. 769. 136385–136385. 36 indexed citations
20.
Okkay, Irmak Ferah, et al.. (2021). Bromelain protects against cisplatin-induced ocular toxicity through mitigating oxidative stress and inflammation. Drug and Chemical Toxicology. 46(1). 69–76. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026